Trial Profile
Effect of Liraglutide as Additional Treatment to Insulin in Patients With Autoimmune Diabetes Mellitus
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Mar 2022
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary) ; Insulin
- Indications Autoimmune disorders; Type 1 diabetes mellitus
- Focus Therapeutic Use
- 15 Oct 2018 Planned End Date changed from 1 Jan 2019 to 1 Jun 2021.
- 15 Oct 2018 Planned primary completion date changed from 1 Nov 2018 to 1 Dec 2020.
- 12 Apr 2018 Planned End Date changed from 1 Nov 2018 to 1 Jan 2019.